Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Hyperbaric Oxygen Therapy in Adult Metabolic Dysfunction-associated Steatotic Liver Diseases (MASLD) Patients : a Randomized Controlled Trial

NCT06619808 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT06619808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06619808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Hyperbaric Oxygen Therapy in Adult Metabolic Dysfunction-associated Steatotic Liver Diseases (MASLD) Patients : a Randomized Controlled Trial
Lead sponsor
Jinling Hospital, China
Phase
Not applicable
Overall status
Recruiting
Start date
July 29, 2024
Completion date
August 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic steatosis, metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver diseases